Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

These data indicate that either alternative vaccine strategies or alternative strategies to protect these patients from pneumococcal disease are required,’ said Michael Chen-Xu, MD.

Chronic lung disease is associated with a higher risk for infection in patients with ANCA-associated vasculitis during both induction and maintenance treatment.

Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Anti-Neutrophil Cytoplasmic Antibody - Associated Vasculitis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ...

Please provide your email address to receive an email when new articles are posted on . Despite an ever-growing array of potential candidate biomarkers for antineutrophil cytoplasmic ...

Cigarette smoking was associated with ANCA-associated vasculitis, particularly myeloperoxidase ANCA-positive vasculitis, according to data published in JAMA Internal Medicine. “We have an incomplete ...

SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally ...

Inhibition of complement fragment C5a with an investigational drug called avacopan demonstrated efficacy against antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and might provide an ...

Swedish investigators report high 1-year rates of renal and patient survival. Patients who have ANCA-associated vasculitis (AAV) with renal involvement have high short-term overall rates of renal and ...

ChemoCentryx, Inc. (NASDAQ: CCXI) shares more than tripled on Tuesday after the firm, in conjunction with Vifor Fresenius Medical Care Renal Pharma, announced positive topline data from its late-stage ...

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) ...

"ANCA Vasculitis Pipeline 2025"DelveInsight's,“ANCA Vasculitis - Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline ...